Multidisciplinary Team Approach to Adverse Effect Monitoring for Bispecifics in MM
March 11th 2024Carol Ann Huff, MD, describes her institution's multidisciplinary approach to monitoring for adverse events when administering bispecific antibodies, including the roles of nurses, pharmacists, and attending physicians.
Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma
March 11th 2024Michael Singel, PharmD; and Carol Ann Huff, MD, discuss how step-up dosing for bispecific antibodies has been implemented in the outpatient setting with monitoring considerations for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome to ensure patient safety.
Overcoming Challenges Related to Bispecific Antibody Adoption in Multiple Myeloma
March 4th 2024Experts discuss challenges related to the implementation of bispecific antibodies for the treatment of multiple myeloma and emphasize the critical role of interinstitutional collaboration in developing bispecific antibody programs.
Public Health Matters Video: The Significance of Language, Cultural Competency in Health Care
February 22nd 2024Tune into this episode of "Public Health Matters" to learn about the importance of cultural competence when addressing health care disparities and promoting health equity in diverse communities as well as special guest Dr. Jose Cucalon Calderon's advocacy work.
The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies
February 19th 2024Matthew Pianko, MD, outlines the logistical considerations involved when implementing bispecific antibodies for the treatment of multiple myeloma, including the roles of the project champion and other stakeholders as part of a multidisciplinary team.